We're sunsetting PodQuest on 2025-07-28. Thank you for your support!
Export Podcast Subscriptions
China's centralized drug procurement system, known as '集采', aims to lower drug prices and resolve tensions between medical professionals and patients. The system involves bulk purchasing to drive down costs, but questions about drug efficacy have emerged.
- '集采' was introduced in 2018 to lower drug prices.
- The system is characterized by bulk purchasing and price negotiations.
- Despite lower prices, concerns about drug efficacy have arisen.
Shownotes Transcript